Trump admin responds to ‘Dilbert’ creator’s plea to ‘help save my life’ by expediting cancer treatment
Cartoonist Scott Adams, best known for creating the “Dilbert” comic strip, recently turned to social media to seek assistance from former President Donald Trump regarding his urgent cancer treatment. Adams, who revealed earlier this year that he is battling metastasized prostate cancer, shared that his healthcare provider, Kaiser Permanente – Northern California, had approved him for a new FDA-approved drug called Pluvicto. Despite this approval, Adams expressed frustration over delays in scheduling the necessary IV treatment, stating, “I am declining fast.” His post on X (formerly Twitter) highlighted the urgency of his situation, as he emphasized that while the drug is not a cure, it offers promising results for many patients.
In response to Adams’ plea, Robert F. Kennedy Jr., the Secretary of Health and Human Services, reached out to offer help, stating that “the President wants to help.” Additionally, Dan Scavino, the White House deputy chief of staff, assured Adams that he was being monitored by Trump, Kennedy, and Dr. Oz, indicating a swift response to his request. Meanwhile, Kaiser Permanente issued a statement assuring that Adams’ oncology team is actively working on his treatment plan, emphasizing their experience with administering Pluvicto to over 150 patients in Northern California since its FDA approval three years ago. This situation underscores the critical nature of timely healthcare access, particularly for patients facing serious illnesses like cancer, and raises questions about the systemic challenges within healthcare systems that can impede prompt treatment.
Adams has been candid about his deteriorating health, revealing in a recent YouTube video that he experiences daily pain and has relied on a walker for mobility. He grimly acknowledged the severity of his condition, stating, “If you’re wondering if I’ll get better, the answer is no, it will only get worse.” Prostate cancer is a significant health concern, affecting approximately 1 in 8 men during their lifetimes and ranking as the second leading cause of cancer-related deaths among men in the United States, following lung cancer. Adams’ situation not only highlights the personal struggles of those battling cancer but also reflects broader issues within the healthcare system that can impact patient outcomes. As he seeks assistance from influential figures, the story serves as a poignant reminder of the urgent need for effective and timely medical care for all patients.
Related articles:
– Link 1
– Link 2
Cartoonist Scott Adams said in a social media post Sunday that he plans to appeal to President
Donald Trump
for help scheduling a cancer drug treatment that he believes could prolong his life.
Adams, the creator of the “Dilbert” comic strip, announced earlier this year that he had metastasized
prostate cancer
.
He wrote in a
post on X
that his healthcare provider, Kaiser Permanente – Northern California, approved his application to receive a new FDA-approved drug Pluvicto.
“But they have dropped the ball in scheduling the brief IV to administer it and I can’t seem to fix that. I am declining fast,” Adams wrote.
BIDEN ‘RANG THE BELL’ AFTER COMPLETING RADIATION THERAPY FOR PROSTATE CANCER
“I will ask President Trump if he can get Kaiser of Northern California to respond and schedule it for Monday. That will give me a fighting chance to stick around on this planet a little bit longer. It is not a cure, but it does give good results to many people.”
Health and Human Services Secretary
Robert F. Kennedy Jr.
responded to Adams’ viral post, asking how to reach him.
“The President wants to help,” RFK Jr. wrote.
COMEDIAN TIG NOTARO DESCRIBES FALLOUT WITH CHERYL HINES OVER HUSBAND RFK JR
Dan Scavino, White House deputy chief of staff and head of personnel, also
responded to Adams,
saying, “No need till [sic] wait until Monday—@realDonaldTrump, @RobertKennedyJr, and @DrOz are all tracking now, Scott.”
Kaiser Permanente told Fox News Digital in an emailed statement: “Mr. Adams’ oncology team is working closely with him on the next steps in his cancer care, which are already underway.”
“Since it was approved by the FDA three years ago, Kaiser Permanente’s nuclear medicine and medical oncology experts have treated more than 150 patients with Lu-177 PSMA (Pluvicto) in Northern California alone. We know this drug and this disease.”
The White House did not immediately respond to Fox News Digital’s request for comment.
Adams said in a video posted to his YouTube channel in May that he is in pain every day and has been using a walker for months.
“If you’re wondering if I’ll get better, the answer is no, it will only get worse,” he said on his “Real Coffee with Scott Adams” show. “There’s only one direction this goes.”
Roughly 1 in 8 men will be diagnosed with prostate cancer during their lifetime, according to the American Cancer Society. Prostate cancer is the second most common cause of cancer death among American men, after lung cancer.
Eric
Eric is a seasoned journalist covering US Politics news.
